Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 May 2017 Biomarkers information updated
- 28 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2010 Planned end date changed from Jul 2009 to Sep 2010 as reported by ClinicalTrials.gov.